Study Finds Muscle Wasting Trajectories in ICU Patients Strongly Linked to Survival: New Insights for Critical Care

The Silent Crisis in the ICU: Muscle Wasting

When we think about critical illness, survival often takes center stage. However, for patients enduring prolonged stays in the Intensive Care Unit (ICU), another silent but powerful threat looms—severe muscle wasting. Known as ICU-acquired weakness, this rapid loss of muscle mass dramatically impacts recovery, rehabilitation, and even survival. But how much muscle do patients actually lose? And can tracking this loss help clinicians predict—and perhaps improve—outcomes? A new study in BMC Anesthesiology offers valuable answers.

Tracking Muscle Loss with AI and CT Scans

Researchers from Berlin analyzed 154 ICU patients, including those suffering from severe COVID-19 and acute pancreatitis, each with extended ICU stays and multiple abdominal CT scans. By harnessing artificial intelligence to analyze changes in the psoas muscle area (PMA) on these scans, the team tracked muscle loss over time and examined how it related to patient survival.

The First Weeks Are Critical

The study revealed that muscle wasting in critically ill patients is both rapid and severe. The most dramatic losses occurred in the first two weeks of the ICU stay, with muscle loss rates peaking at over 2% per day—sometimes exceeding 4% per day. Over the course of hospitalization, the median total loss of psoas muscle was an astonishing 48.3%. Notably, non-survivors lost significantly more muscle than those who survived.

Defining the Danger Zone: Muscle Loss and Survival

By analyzing survival alongside muscle loss rates, the researchers identified clear thresholds that separate higher and lower survival outcomes. A daily muscle loss greater than 4% predicted the lowest survival rate—just under 40%. Patients who lost muscle at a slower rate (less than 2% per day) had a much higher survival probability of nearly 85%. Other risk factors for poor outcomes included higher visceral fat and organ failure scores, while more baseline muscle had a protective effect.

Why This Matters for Patients and Clinicians

This research highlights the importance of monitoring muscle loss in the ICU—not just as a marker of disease severity, but as a potential guide for timely interventions like nutrition, physiotherapy, or changes in sedation strategy. Importantly, the use of existing CT scans and AI tools means this approach could be implemented without adding burden or risk for patients.

Key Takeaways

Muscle wasting in ICU patients is most severe during the first two weeks of critical illness.

Daily muscle loss rates above 4% are strongly linked to poorer survival.

Non-survivors lost more muscle overall—over 56% of psoas muscle area—than survivors.

Higher baseline muscle mass may help protect against poor outcomes.

AI-powered CT analysis offers a practical, precise way to monitor muscle loss, potentially informing better care.

Citation:

Kolck J, Hosse C, Fehrenbach U, Beetz NL, Auer TA, Pille C, Geisel D. (2025). The extent of Skeletal muscle wasting in prolonged critical illness and its association with survival: insights from a retrospective single-center study. BMC Anesthesiology, 25:266. https://doi.org/10.1186/s12871-025-03142-7